- Home
- ABEO vs RFMZ Comparison
ABEO vs RFMZ Comparison
Compare ABEO & RFMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- RFMZ
- Stock Information
- Founded
- ABEO 1974
- RFMZ 2021
- Country
- ABEO United States
- RFMZ United States
- Employees
- ABEO N/A
- RFMZ N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- RFMZ Trusts Except Educational Religious and Charitable
- Sector
- ABEO Health Care
- RFMZ Finance
- Exchange
- ABEO Nasdaq
- RFMZ Nasdaq
- Market Cap
- ABEO 289.2M
- RFMZ 314.9M
- IPO Year
- ABEO 1980
- RFMZ N/A
- Fundamental
- Price
- ABEO $5.49
- RFMZ $12.98
- Analyst Decision
- ABEO Strong Buy
- RFMZ
- Analyst Count
- ABEO 6
- RFMZ 0
- Target Price
- ABEO $18.17
- RFMZ N/A
- AVG Volume (30 Days)
- ABEO 1.0M
- RFMZ 76.6K
- Earning Date
- ABEO 11-13-2025
- RFMZ 01-01-0001
- Dividend Yield
- ABEO N/A
- RFMZ 7.43%
- EPS Growth
- ABEO N/A
- RFMZ N/A
- EPS
- ABEO 0.99
- RFMZ 0.65
- Revenue
- ABEO $400,000.00
- RFMZ N/A
- Revenue This Year
- ABEO N/A
- RFMZ N/A
- Revenue Next Year
- ABEO $324.71
- RFMZ N/A
- P/E Ratio
- ABEO $5.69
- RFMZ $21.49
- Revenue Growth
- ABEO N/A
- RFMZ N/A
- 52 Week Low
- ABEO $3.93
- RFMZ $11.28
- 52 Week High
- ABEO $7.54
- RFMZ $14.57
- Technical
- Relative Strength Index (RSI)
- ABEO 45.42
- RFMZ 48.35
- Support Level
- ABEO $5.21
- RFMZ $12.97
- Resistance Level
- ABEO $5.73
- RFMZ $13.25
- Average True Range (ATR)
- ABEO 0.24
- RFMZ 0.13
- MACD
- ABEO 0.06
- RFMZ -0.02
- Stochastic Oscillator
- ABEO 59.63
- RFMZ 21.21
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.